Merveille.ai

Merveille.ai, a wholly-owned subsidiary of Hoth Therapeutics, has achieved significant breakthroughs in the field of obesity treatment. By utilizing advanced artificial intelligence, Merveille.ai identified a promising new therapeutic candidate and has since filed a strategic patent application.